Author

A. Visvikis

Observed names: A Visvikis, ANASTASIOS VISVIKIS, Anastasios Visvikis, Visvikis, Anastasios

Observed institutions: Aristotle University of Thessaloniki, Metropolitan Hospital Center, AHEPA University Hospital, Hellenic Cooperative Oncology Group, Hospital Agioi Anargyroi, Metaxa Hospital, Metropolitan Hospital

ORCID: 0000-0002-3146-1593

Observed ORCID: 0000-0002-3146-1593

OpenAlex ID: A5075650620

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

2009 · C. Christodoulou, A. Pervena, et al. · Oncology · 230

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

2012 · A. Bamias, U. Dafni, et al. · Annals of Oncology · 100

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

2001 · D. Pectasides, G. Aravantinos, et al. · Annals of Oncology · 34

Combination Chemotherapy With Carboplatin, Docetaxel, and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase II Study

1999 · D. Pectasides, A. Aspropotamitis, et al. · Journal of Clinical Oncology · 28

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial

2000 · D Pectasides, A Visvikis, et al. · European Journal of Cancer · 26

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

2001 · D Pectasides, H P Kalofonos, et al. · PubMed · 23

Posterior Reversible Encephalopathy Syndrome With Concurrent Nephrotic Syndrome in a Patient Treated With Pazopanib for Metastatic Renal Cell Carcinoma: Case Report and Review of the Literature

2016 · Nikolaos Miaris, Maria Maltezou, et al. · Clinical Genitourinary Cancer · 19

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer

2002 · D Pectasides, A Visvikis, et al. · European Journal of Cancer · 15

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer

2020 · A. Visvikis, SM Kyvelou, et al. · Cancer Management and Research · 14

PDF

Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience

1999 · D. Pectasides, G. Aravantinos, et al. · Oncology · 13

Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma

2020 · ELIZABETH PSOMA, GEORGIA-ANGELIKI KOLIOU, et al. · Anticancer Research · 8

PDF

Squamous Cell Carcinoma Antigen, Circulating Immune Complexes, and Immunoglobulins in Monitoring Squamous Cell Carcinoma of Head and Neck

1999 · P. Makrantonakis, D. Pectasides, et al. · American Journal of Clinical Oncology · 8

Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer

2021 · Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al. · Cancers · 7

PDF

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing

2023 · Elena Fountzilas, Maria Kouspou, et al. · International Journal of Molecular Sciences · 3

PDF

Combination chemotherapy with carboplatin (CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study

1999 · D. Pectasides, A. Aspropotamitis, et al. · European Journal of Cancer · 3

Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?

2023 · Joseph Sgouros, Stefania Gkoura, et al. · Clinical Colorectal Cancer · 2

Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens

2022 · Kyriaki Papadopoulou, Georgia-Angeliki Koliou, et al. · Urologic Oncology Seminars and Original Investigations · 2

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

2021 · Elena Fountzilas, Vassiliki Kotoula, et al. · Frontiers in Oncology · 2

PDF

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece––the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)

2018 · Georgiops Tsironis, Konstantinos Koutsoukos, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2

Successful management of extracranial metastases from cerebral high-grade oligodendroglioma: report of a case with literature review.

2002 · D Pectasides, A Halikia, et al. · PubMed · 2

The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer. A Hellenic Cooperative Oncology Group Phase II Study

2024 · Michalis Liontos, Anna Goussia, et al. · Clinical Genitourinary Cancer · 1

Prognostic significance of elements of the adaptive immunity in the microenvironment of epithelial ovarian cancer

2019 · P. Foukas, G.-A. Koliou, et al. · Annals of Oncology

Abstract P4-08-13: Prognostic significance of CD8+ tumor-infiltrating lymphocytes (TILs) in patients with early breast cancer (EBC) treated with dose-dense sequential adjuvant chemotherapy (dds-CT). An observational study (ACTRN12616001043426)

2019 · HP Kourea, T Koletsa, et al. · Cancer Research

2019 · Georgiops Tsironis, Koutsoukos, Konstantinos, et al. · Figshare

Combination chemotherapy with cis-platin (CDDP), epirubicin (EPI), and docetaxel (DOC) in transitional cell urothelial cancer (TCC). A phase II study

1999 · D. Pectasides, A. Visvikis, et al. · European Journal of Cancer

Works count: 25

Citation count: 542

H-index: 10

I10-index: 10